Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > June 21 PP

<< Previous

Bullboard Posts

Next >>

Comment by xodcodeon Jun 13, 2024 3:46pm

183 Views

Post# 36087831

RE:RE:June 21 PP

Given the difficulty with the recent $1 million PP's, it is difficult to imagine how TLT management plan to raise $10 million at $0.22 unless they already have a commitment, one with strings attached like milestone promises going forward, Kind of a quasi JV commitment!

I remain very optimistic especially with the expanded available markets implied by the recent news releases.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property